Good morning. I'll be your conference operator today. At this time, I'd like to welcome everyone to NewLake Capital Partners' 2023 year-end conference call. Today's call is being recorded. I will now turn the call over to Valter Pinto, Managing Director of KCSA Strategic Communications. Please go ahead. Thank you, operator. Good morning, and welcome everyone to the NewLake Capital Partners' fourth quarter and full year 2023 earnings conference call. I'm joined today by Gordon DuGan, Chairman; Anthony Coniglio, President and Chief Executive Officer; Lisa Meyer, Chief Financial Officer; and Jarred Anenberg, Senior Vice President and Head of Investments. Before we begin, I'd like to remind everyone that statements made during today's conference call may be deemed forward-looking statements within the meaning of the safe harbor of the Private Securities Litigation Reform Act of 1995, and actual results may differ materially due to a variety of risks and uncertainties and other factors. For a detailed discussion of some of the ongoing risks and uncertainties in the company's business, I refer you to the press release issued this morning and filed with the SEC on Form 8-K, as well as the company's 10-K and other reports filed periodically with the SEC. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. FFO and AFFO are supplemental non-GAAP financial measures used in the real estate industry to measure and compare the operating performance of real estate companies. A complete reconciliation containing adjustments from GAAP net income attributable to common shareholders to FFO and AFFO and definitions of terms are included at the end of our press release. Please refer to that press release for more information. The company's guidance is based on current plans and assumptions and subject to the risks and uncertainties more fully described in the company's filings with the United States Securities and Exchange Commission. This outlook reflects management's view of current and future market conditions, including assumptions such as the pace of future acquisitions and dispositions, rental rates, occupancy levels, leasing activity, uncollectible rents, operating and general administrative expenses, weighted average diluted shares outstanding, and interest rates. With that, it's my pleasure to turn the call over to Mr. Gordon DuGan. Gordon, please go ahead. Thank you, Valter, and thank you everyone for joining our call. During 2023, NewLake outperformed across our key financial metrics year-over-year, despite a very challenging year for the cannabis industry and REITs generally. Against this difficult backdrop, the company delivered growth as well as record revenue, record net income, and record AFFO. Additionally, we raised our dividend in the fourth quarter, and today we announced another increase in our dividend for the first quarter of 2024. We have raised our dividend every year since the company starting in 2019. Since our IPO in 2021, the company has increased its dividend 67%, paying out over $80 million or $3.85 per share in dividends to shareholders. There are a few items I'd like to highlight from this past year. As we expected to occur at some point, in 2023, we experienced our first tenant issue in the portfolio. Our team was well prepared and worked diligently to resolve the issue. We ended 2023 with 100% of our invested capital, generating returns for our investors and 100% rent collection for the fourth quarter. This is a solid foundation to build upon as we embark on 2024 and drive for continued growth. During 2023, we also took advantage of a low stock price and aggressively repurchased our common shares, buying back nearly 12 million of our stock at an average price of $13 per share, which was nicely accretive, particularly where the stock price sits today and what we see as a future upside for investors. As stewards of our shareholders' capital, we are keenly focused on maximizing returns, and we will continue to apply this return-oriented approach as we evaluate future buyback opportunities. Lastly, our business generates significant free cash flow, as demonstrated by our Q4 2023 payout ratio of 78%. There is significant cushion for our dividend and potential for growth as we manage to our goal of an 80%-90% payout ratio. As we look to the future, we see ample opportunities for growth. With virtually no debt and $89 million available to us under our credit facility, which has an attractive interest rate and does not mature until 2027, we are in a very good position to capitalize on our strengths and deploy capital into quality transactions. In closing, I'm proud of what we have accomplished in 2023. I continue to be very bullish on the long-term prospects for our company, and I'm excited for the opportunities that lie ahead. With that, I'll turn the call over to our CEO, Anthony. Thank you, Gordon, and thank you everyone for joining our call today. As Gordon said, 2023 was a record year for NewLake, and I want to thank our team for their hard work during the year, delivering solid results for our shareholders. As we look forward, I'd like to discuss a number of potential catalysts in 2024 for the cannabis industry and for NewLake. There have been many headlines recently, and specifically, President Biden's mention of his cannabis policy during last week's State of the Union address has many investors interested to understand what these potential catalysts mean for NewLake. So let's look at these federal, state, and legislative catalysts. First and foremost, we're awaiting the DEA's decision regarding the recommendation by the Health and Human Services Department to reschedule cannabis from Schedule I to Schedule III. Such a move would eliminate the onerous Section 280E taxation and result in greater free cash flow for the industry, including our tenants. There are few examples where a REIT's entire tenant base has an opportunity to experience a meaningful improvement in credit risk profile and significant increase in cash flow overnight from a single catalyst, such as this expected move to Schedule III. Furthermore, we believe a rescheduling to Schedule III will have a positive impact on operator valuations, allowing them to recapitalize their balance sheets by issuing equity and paying down debt. Not only would this improve balance sheet health, but would also reduce their interest expense and further improve their cash flows. This would be yet another improvement in the credit risk profile of the industry, and specifically, our tenant base. At the state level, Ohio approved recreational cannabis at the ballot box in November, and we expect an adult use program to launch later this year. Many of our tenants have operations in Ohio, such as Ayr, Acreage, Cannabist, Cresco, Trulieve, and PharmaCann, and their financial performance is expected to benefit from the anticipated increase in sales in this state of nearly 12 million people. We're excited about the potential credit improvement within our tenant base, as well as the potential for incremental investment opportunities in the state. Additionally, we await the Florida Supreme Court's decision regarding adult use cannabis on the Florida ballot. Most observers expect the state Supreme Court to allow the ballot initiative to proceed. With over 21 million people, an adult use program in Florida will benefit our Mount Dora, Florida, tenant, Curaleaf, as well as our other tenants that have operations in the state, notably Trulieve, Ayr, Cresco, and The Cannabist, creating yet another opportunity for our tenant base to increase scale and profitability. Two weeks ago, Virginia's legislature approved legislation to implement an adult use program, which was approved back in 2021. The legislation is awaiting the governor's signature, with the potential to have an adult use program launch in 2025. With only three operators serving this state with 8.7 million people, there is the opportunity for the incumbents to lead in the adult use market launch. Our tenant, The Cannabist, owns 10 of the 21 operational dispensaries in Virginia and is poised to benefit from this conversion to adult use, not to mention the potential for additional investment opportunities. Let's turn to New York. With New York finally allowing the original medical market operators to participate in the adult use market, we should see some of our tenants begin to benefit from their significant investments into that state, such as Acreage, The Cannabist, Cresco, Curaleaf, and PharmaCann. We're also hearing that Safer Banking is again back in the dialogue. Passing the Senate Banking Committee last September, this bill is now becoming the potential vehicle for the anti-Operation Choke Point legislation, now known as Section 10 of the SAFER Banking Act. While we are cautious about predicting legislative action at the federal level, it's notable that Congress continues to have dialogue around this bill. Better access to financial services benefits all market participants, and we're certainly rooting for passage of SAFER. So what does all this mean? Action in the administrative branch with potential for rescheduling. There's action in the legislative branch around SAFER Banking and other cannabis-oriented legislation, and there's action at the state level, where, according to Pew Research, more than 50% of our country's population resides in a state with adult use cannabis. While we think it strongly confirms that cannabis remains on the inevitable path to normalization and ultimately legalization, 2024 could be the year to start realizing some of those industry catalysts, which should benefit our tenants, our portfolio, and of course, our investors. With that, I'll turn it over to Jared. Thanks, Anthony. For my remarks, I will be talking about our current portfolio, activity for the quarter, tenant and industry insights, and expectations. Starting with our current portfolio, as of December 31st, we had committed a total of $428 million across 17 dispensaries and 14 cultivation facilities in 12 states, with 13 tenants, representing approximately 1.6 million sq ft covered. Our cost basis in retail properties is $389 per sq ft, and in cultivation properties, it's $252 per sq ft. Both metrics are well below replacement cost. 71% of our current rent is from publicly traded operators, and 93% is from properties in which the tenant is vertically integrated in the state. EBITDA coverage for the latest available quarter was 3.7x for cultivation and 10.3x for dispensaries, a slight decrease for cultivation and slight increase for dispensaries from the previous quarter. Please note we use estimates where appropriate, given each company reports slightly differently on a property-level basis. As I discussed in our last call, in the fourth quarter, we finalized a lease agreement with Revolutionary Clinics in Massachusetts, and the new management team is executing on their transition plan. Additionally, in November, our Pennsylvania tenant, Calypso, was sold to Canvas Acquisition Corp, a new entrant into the industry.... In connection with the sale and under the terms of the revised lease agreement, NewLake has agreed to provide up to $3 million in tenant improvement allowance and has received a 6-month rent escrow. We visited the facility two weeks ago to meet with the new team. New strains were in the ground and new processes are being implemented. In December, Pennsylvania passed a bill that will provide independent cultivators in the state, such as Calypso, with three dispensaries, allowing for vertical integration in the state and the potential for increase in both sales and margins. Additionally, Pennsylvania's governor included taxes from adult-use cannabis sales in his budget for 2025. That action, together with five of the six bordering states having adult-use cannabis sales, is expected to put pressure on the state's legislature to enact adult-use legislation. In regard to our properties under development, we deployed $8.8 million of TI allowance in the fourth quarter and $14.8 million in total for the full year, the majority of which went to our projects for The Mint in Phoenix and C3's expansion in Missouri. As of year-end, we had $14.4 million in TI outstanding, and we expect the majority to be drawn down by the end of the second quarter as both Mint and C3's projects are completed. The team was in Missouri a few weeks ago, touring the two properties we own in the state. Specifically, we were excited to see C3's expansion that we've been funding for the past year. Construction is proceeding well, and the team is excited to put plants in the ground to meet the growing demand in the state. Looking broadly at our tenant base, we continue to see financial improvements as the focus on operational efficiencies have started to take effect and combined with the wholesale pricing stabilization we've been seeing over the past few quarters. Compared with the same quarter last year, many of our tenants have been able to maintain top-line revenue with an average gross margin of 40%, while increasing EBITDA from 15.5%-20% on average across the portfolio. Additionally, we are seeing operators shore up their balance sheets and provide themselves with additional runway. Ayr restructured and extended their debt until the end of 2026. The Cannabist announced a debt for equity conversion, and Trulieve announced a $130 million debt reduction. These improvements will have an even greater impact on our tenant credit in the event of a rescheduling, as we estimate our tenants could save an aggregate of over $400 million annually in federal taxes with 280E relief, about 20% of annual gross profits. As we look forward, we've seen an uptick in deal activity since the start of the year, as operators are becoming more optimistic about potential Schedule III and new state programs coming online. As always, we will maintain discipline when deploying additional capital, focusing on operators with strong financial profiles, quality management teams, and in states with regulatory frameworks that provide the best opportunity for long-term success. With that, I'll turn it over to Lisa. Thank you, Jared. For the fourth quarter of 2023, our portfolio generated total revenue of $13 million, an increase of 6.4% year-over-year. The growth was mainly driven by acquisitions, TI fundings, increasing base rents, annual rent escalators, and income related to the valuation of warrants. The increase in rental revenue was partially offset by reduced rent collections from Revolutionary Clinics and Calypso, for which we executed lease amendments in the fourth quarter of 2023. The $13 million of revenue for the fourth quarter included approximately $1.3 million of non-recurring revenue associated with Revolutionary Clinics, where we recaptured a $315,000 security deposit, $480,000 of delinquent rents for periods prior to the fourth quarter, and $522,000 of non-cash revenue related to the valuation of the warrants received with the lease amendment and forbearance agreements. Net income attributable to common shareholders for the three months ended December 31, 2023, totaled $6.9 million, or $0.34 per share. While fourth quarter AFFO was $10.8 million, a decrease of 1.2% compared to the same period in 2022. On a per-share basis, AFFO increased by $0.01 to $0.51 per share in the fourth quarter of 2023 compared to the prior year, driven by the value created for our shareholders through our share repurchase program. During the three months ended December 31, 2023, we invested $8.8 million in tenant improvements, with $14.4 million in unfunded commitments at quarter end. Moving to the full year 2023 financial results, our portfolio generated total revenue of $47.3 million, an increase of 5.1% year-over-year. Net income attributable to common shareholders for the full year of 2023 totaled $24.6 million, compared to $22 million for the full year of 2022. For the full year of 2023, AFFO totaled $40.7 million, or $1.89 per share, an increase of 5.2% year-over-year. In 2023, we adopted ASC 326, Financial Instruments Credit Loss, commonly called CECL… we were required to record an expected credit loss as defined by their guidance. The amount of the credit loss recorded was $167,000. As of December 31, 2023, the $5 million note receivable is the only financial instrument that the company holds that falls under this guidance. The company is unaware of any information that would lead us to believe that we will not fully recover our $5 million investment in this loan. On December 14, 2023, the company declared a fourth quarter 2023 cash dividend of $0.40 per share of common stock that was paid on January 12, 2024. On March 8, the company's board of directors raised the first quarter 2024 cash dividend to $0.41 per share of common stock, equivalent to an annualized dividend of $1.64 per share of common stock. The dividend is payable on April 15, 2024, to stockholders of record at the close of business on March 29, 2024. For the year ending 2023, we repurchased 908,394 shares of our common stock at an average price of $13 per share. of December 31, we continued to have a strong balance sheet, with $412.3 million in gross real estate assets and only $1 million of outstanding debt on our $90 million revolving credit facility. We have approximately $115 million of liquidity, comprised of cash and the remaining availability under our credit facility. We believe the company is well positioned to execute our business strategy to grow earnings for investors as we deploy capital. Now, I would like to turn the call back to the operator for Q&A. Thank you. Ladies and gentlemen, at this time, we will be conducting a question-and-answer session. If you'd like to ask a question, you may press star one on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You may press star two if you would like to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star key. Our first question comes from the line of Pablo Zuanic with Zuanic & Associates. Please proceed with your question. Good morning, everyone. Anthony, I guess I don't want to put words in your mouth, but based on the forward commentaries that you made, comments that you made, and the fact that you, I think, funded $9 million allowances in the fourth quarter of $14 million for all of 2023, there's been a bit of a ramp, right? It seems to me that over the past 12 months, you've been a bit gun-shy in terms of new deals, but now you're becoming more, I guess, more active. The outlook is apparently improving the way you see it. So I don't know if you can talk about the pipeline, but in terms of just, you know, funded commitments or pipeline, tell us what you see there over the next 6 months. And am I right in saying that you've been a bit gun-shy, but now becoming a bit more proactive? Yeah. Pablo, thank you for the question. I'll make a couple of comments and then hand it over to Jared to talk a little bit about the pipeline. I would say that indeed, during 2023, we were a little bit gun-shy. Really, what we were doing in 2023 is we were watching the landscape evolve. We wanted to make sure that we understood how the operators were going to respond and react to the difficult operating environment. And we also wanted to understand what was happening with from a rates perspective when we think about our cost of capital in putting out transactions and agreeing to. So as we're sitting here in 2024, I think there's a much more stable landscape that allows us to make better informed decisions for our shareholders. Jared, why don't you talk a little bit about what we're seeing on the pipeline section? Sure. And as I mentioned, we are seeing more deal activity, I think, in the past few months than we had seen in the majority of 2023, as operators are looking forward, and I think they're feeling more bullish, not only on Schedule III and new states coming online, but as you can see in, in financial reports that are coming out, the operators are on better financial footing. So for us, it's really finding the right transactions with the quality operators in states that are limited license, that we can deploy capital that's accretive and at rates that make sense for both us and the operators. Thank you, Jared. disciplining going forward. Understood. And just to follow up on that, in terms of the options that operators have out there, I know there are shorter-term loans, right? Mortgages, five years. I know you're a sale-leaseback. I mean, can you talk about the competitive environment in terms of the options out there? On the one hand, we hear about Needham Bank, we hear about First Citizens Bank. I understand it's not the same as sale-leaseback, but there seem to be more options in, on the creative front for operators, but correct me if I'm wrong in terms of my interpretation of that. But at the same time, in terms of sale-leaseback, the feedback we hear from some operators is that given potential reform coming at the federal level, they don't want to have to tie up assets for, you know, for such a long period of time, 15 years or more. So in that context, is it fair to say that maybe the demand, because of competition and because of the outlook, may be less for sale-leaseback, or again, is that the wrong interpretation? Thank you. ... Pablo, I would say that it depends on the organization's outlook for the future. We had many conversations with operators two years ago who believed that by 2023, they would have seen their cost of capital drop by, in some cases, 400, 500 basis points. And here we sit today, and that cost of capital has only gone up. So yes, there will always be operators in the sector that believe that just around the corner, a significant drop in their cost of capital is going to occur. I think also it's important to note that all of these capital market options, to the extent that more come in for, and each has relatively very, very little financial flexibility. To see some additional providers come in is a significant positive, in our opinion, because we want the tenant base and want the operators to have more options available to them. Because these options do coexist. Somebody that may want a portion of their capital structure funded with shorter-term debt will also have a portion of their capital structure funded with a sale leaseback. So it's not always an or, I think it's an and, because we serve different purposes. Most notably, the bank facility usually provides a discount in advance rate relative to where you'd get at a sale leaseback. So a bank may lend 55 or 60 cents on the real estate value, non-cannabis, whereas given our 5-year history of underwriting transactions, our ability to understand this industry and specifically this real estate asset class allows us to provide fair value for those assets. Jared, anything you want to add to that? No, I think you really covered it. We always look at sale-leasebacks as a tool in the tool belt. It shouldn't be the only thing an operator is doing to fund expansion. I think we've been competing with these lower LTV bank mortgages since inception. We've been seeing them for five years, and I think the same thing goes with shorter-term debt and operators having that optimistic view of the future. We've been seeing it for five years. It happened in April of 2019 when we started the business as well. Thank you. One last one. You know, more on the technical front in terms of the stock, right? In terms of being able to attract more investors into the stock, you know, what is under your control right now? Or is it more just having to wait for up listing and the stock having more custody? Any color you can share in that regard would help. Thank you. Yes, thank you for the question. This is very important. A couple of things I want to mention. Number one, we have spent a significant amount of effort to be more visible for our investors, to have a greater outreach to the investor community, both on the retail side as well as the institutional side. We're participating in a conference later this week and have quite a few one-on-ones set up with institutional investors. And so we have a dual-pronged approach to try to build up our investor base. But at the end of the day, it's about execution. And so for us, we spend a lot of time focused on executing our business plan, delivering value for investors, and letting the results really be the most important mouthpiece for the company. I would note for you that as investors look at our most recent investor presentation, we've included a little bit more, not a little bit, we've included more direct comparison to the significant discount that we think NewLake is trading at. And so we think there's a real opportunity for investors to not only have a quality dividend getting paid by NewLake on a quarterly basis, but when you look at that undervaluation that we believe exists in our stock price today compared to peers, we think there's a real opportunity for investors. And so we're going to be focusing folks on that opportunity more and more as we continue the dialogue. With respect to uplisting, we are very aware of what TerrAscend and Curaleaf have been able to accomplish, vis-a-vis custody and specifically Pershing, which is one of the largest prime brokers in the sector, Bank of New York company. And so we value what that would mean for NewLake. We understand that that's a critical component to closing that valuation gap, and we're spending a lot of time and energy to try to figure it out. Understood. Thank you. As a reminder, it is star one to ask a question. Our next question comes from the line of Nick Anderson with Roth MKM. Please proceed with your question. Yeah, good morning. Thanks for taking the questions. First one for me, just on the underwriting process. I appreciate the commentary around rescheduling. Does this change the way you evaluate maybe the smaller, less profitable operators in the space? Just your sense on how you view the rescheduling catalyst in regard to your capital deployment opportunity. Thank you. Thanks, Nick. So I wouldn't... So the quick answer is, we've always underwritten, I think, more conservatively, and we aren't really underwriting any differently in the face of Schedule Three. Our assumption is taxes need to be paid, and the cash flow profiles of operators doesn't change immediately. Obviously, it's an upside if they do. From a smaller, unprofitable operator perspective, our focus at this point is really on the more profitable operators in the sector, whether that's public or private. I think a lot of attention is obviously paid towards the larger public operators, but there are private operators, both in our portfolio and probably out, that are making money after taxes. I think that's where our energy is focused. ...And I'd also point out our focus on EBITDA coverages. I think that has served us very well over the last 18 months, in how the performance of the portfolio has delivered for us, during this very, very difficult time period for the industry. So we're gonna continue to stay focused on property-level cash flows. Okay, I appreciate that. Then second one for me, just on uplisting in the U.S. here. You discussed the TSX, but just with rescheduling discussions escalating here, wondering if you can kind of lay out the potential pathway to a major U.S. exchange listing and just what you think will be needed to get there? Yeah. Thank you. We operate -- the first thing I wanna say is we operate the company to qualify, to, to qualify with all New York Stock Exchange and NASDAQ listing requirements. So we are running the company to be ready to uplist once they will, once they will have us, based on a rule change. It is very hard, and I certainly am not going to predict when NASDAQ will change their posture. Do I believe that a Schedule Three alone will do it? I'm doubtful that it is. Do I believe safer banking without a safe harbor, would do it by itself? I'm doubtful it would. Do I think safer banking can get a safe harbor? There is significant lobbying effort occurring to get a safe harbor for exchanges. But can I predict that it will happen? No, it won't. Would another Cole Memo 2.0 do it on its own? I doubt it. Can all of these together, if you get all of that and run the table, does that change their mind? Again, hard to predict. At the margin, better, but hard to predict. But as we all know, hope isn't a strategy. So, we continue to run the company so that we can uplist as soon as we're available to, but we're also looking for alternatives, and hence the focus on TSX. Hey, it's Gordon DuGan. I just wanna add that it is a bit of a personal frustration that the New York Stock Exchange, you know, continues to let IIPR list, raise capital and do everything that we're doing. The businesses are identical, and there's really no good reason that we're not listed and they are. I mean, there isn't a single, not a single good reason that they're listed and we're not. So it is a continued frustration. So, you know, thank you for allowing me to vent, because there's absolutely no difference in our businesses. No, I appreciate the color. That's it for me. I'll pass it on. There are no other questions in the queue. I'd like to hand it back to Anthony Coniglio for closing remarks. Thank you, everybody, for joining our call today. We look forward to, hopefully, an exciting and positive 2024. Have a great week. Ladies and gentlemen, this does conclude today's teleconference. Thank you for your participation. You may disconnect your lines at this time, and have a wonderful day.